Log In
Print this Print this

Vigil vaccine (formerly FANG vaccine)

  Manage Alerts
Collapse Summary General Information
Company Gradalis Inc.
DescriptionAutologous tumor-based vaccine composed of a plasmid encoding GM-CSF and a bifunctional short hairpin RNA (shRNA) that downregulates TGFB1 and TGFB2
Molecular Target Transforming growth factor (TGF) beta 1 (TGFB1) ; Transforming growth factor (TGF) beta 2 (TGFB2)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today